News Releases

BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of

LabCorp and other commercial labs will have the ability to perform more than 2 million tests per week by June INDIANAPOLIS , May 19, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY ) today announced its Elecsys® Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab

Employers Now Have Access to LabCorp’s High-Quality COVID-19 Testing Capabilities Including Its New Fingerstick Antibody Blood Test BURLINGTON, N.C. --(BUSINESS WIRE)--May 14, 2020-- LabCorp (NYSE: LH) announced today it is launching a new return to work service for employers. Many U.S.

Consumers Now Have Access to the At-Home Test Collection Kit Online with No Upfront Costs, In Addition to Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--May 12, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding

BURLINGTON, N.C. --(BUSINESS WIRE)--May 6, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Bank of America Securities 2020 Health Care Conference on Wednesday, May 13 , at 10:20 a.m. ET .

Expanding Access to Tests Through LabCorp’s Wide Network of Doctors, Healthcare Providers, and Now Online BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that its COVID-19

BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 13 , at 9:00 a.m. Eastern Daylight Time via the company website at www.LabCorp.com . An archived replay of the audio webcast will be

Q1 revenue of $2.82 billion , up 1% over $2.79 billion last year Q1 diluted EPS of ( $3.27 ), which include goodwill and other asset impairments of $4.43 per share Q1 adjusted EPS of $2.37 , which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic Q1 free cash flow

Locations include nearly 2,000 LabCorp patient service centers including more than 100 LabCorp at Walgreens locations, and thousands of physicians’ offices BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 27, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in

Tests Assist in Confirming the Presence of Antibodies to the Virus that Causes COVID-19 BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced it will expand serological

Initial Distribution Prioritized for Frontline Healthcare Workers and First Responders BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 21, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it has received an Emergency

Groundbreaking Registry Aims to Help Researchers Accelerate COVID-19 Diagnosis, Treatment and Prevention Strategies BURLINGTON, N.C. & ALPHARETTA, Ga. --(BUSINESS WIRE)--Apr. 9, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and

LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19   MENLO PARK, Calif., April 8, 2020 — Pacific

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 6, 2020-- LabCorp (NYSE: LH) will release its first quarter of 2020 financial results before the market opens on Wednesday, April 29, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Company also preparing to support faster point-of-care testing for COVID-19 in hospitals once available BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2020-- LabCorp (NYSE: LH), a leading global life services company that is deeply integrated in guiding patient care, today announced that it is

Differentiated approach may improve detection methods and inform vaccine discovery for COVID-19 Other industry leaders including LabCorp, through its Covance drug development business, Illumina, and Providence join forces to accelerate this critical effort SEATTLE and REDMOND, Wash.

LabCorp ‘Wait Where You’re Comfortable’ and Mobile Check-In Options Reinforce Social Distancing Protocols BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it is dedicating the

The LabCorp 2019 Novel Coronavirus (COVID-19), NAA Test is for Use by Clinicians with Patients Who Meet COVID-19 Evaluation Criteria BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its

BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami Beach on Tuesday, March 10 at 8:30 a.m. ET .

Revenue: Q4 of $3.0 billion , up 6% over 2018; Full year of $11.6 billion , up 2% over 2018 Diluted EPS: Q4 of $2.32 , up from $1.56 last year; Full year of $8.35 , down from $8.61 last year Adjusted EPS: Q4 of $2.86 , up 13% over 2018; Full year of $11.32 , up 3% over 2018 Free Cash Flow: Q4 of

Receives Designation as a Best Place to Work for LGBTQ Equality For Third Consecutive Year BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 21, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it received a perfect

BURLINGTON, N.C. & CARLSBAD, Calif. --(BUSINESS WIRE)--Jan. 14, 2020-- LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion diagnostics as well as other future oncology and precision medicine

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE: LH) will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, Feb. 13, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Specialized Expertise, Coordinated Capabilities and Targeted Investments Designed to Accelerate Development and Reduce Risk for Sponsors BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care,

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2020-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14 at 1:30 p.m. (PT) .